Streetbeat News

Partnerships

QBTS

D-Wave Quantum Inc. and Japan Tobacco's pharmaceutical division are collaborating on a proof-of-concept project to use quantum computing and AI for drug discovery. The project aims to enhance the speed and quality of AI-driven drug design, potentially setting a new standard in the field.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 11:15 am

ADEA

VZIO

Adeia Inc. has renewed its intellectual property license agreement with VIZIO, allowing VIZIO continued access to Adeia's media IP portfolio. This multi-year renewal highlights the ongoing value of Adeia's technology in the digital entertainment sector.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 11:12 am

ZPTA

Zapata AI has signed its first commercial agreement with MAG Aerospace, focusing on developing foundational elements for MAG's next-generation integrated surveillance platform.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 11:09 am

CDXS

MRVI

Codexis has entered a licensing agreement with Alphazyme for its life science enzymes, allowing Codexis to focus on pharmaceutical growth. The deal includes sales-based royalties and aligns with Codexis' strategic shift to divest non-core assets.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 11:08 am

LFCR

Lifecore Biomedical, Inc. (NASDAQ:LFCR) has secured a multi-year contract with Lindy Biosciences to provide CDMO services for Lindy's microglassification technology, potentially generating over $5 million in revenue. This positions Lifecore as Lindy's preferred CDMO partner.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 11:01 am

META

Meta Platforms Inc. plans to start producing its Quest VR headsets in Vietnam by 2025, creating 1,000 jobs. This move aligns with Meta's strategic initiatives in mixed reality and AI, as highlighted by CEO Mark Zuckerberg at the Meta Connect 2024 event.

Portfolio Pulse from Rounak Jain

October 01, 2024 | 10:58 am

PHR

Phreesia has announced the renewal of its contract with the CMS Innovation Center for the use of the Patient Activation Measure, extending the agreement through 2029.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 10:53 am

PINC

Premier, Inc. has entered a partnership with Prestige Ameritech, exchanging its holdings in S2S Global for a 20% minority interest in Prestige. This increases Premier's total ownership in Prestige to approximately 24.2%.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 10:32 am

GLPG

Excellos has been chosen to manufacture Galapagos' CAR-T cell therapy candidate, GLPG5101, for the ATALANTA-1 study targeting relapsed/refractory non-Hodgkin lymphoma. This follows FDA clearance for the study.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 10:07 am

BNTX

BioNTech, along with its AI subsidiary InstaDeep, is showcasing its advancements in AI for personalized vaccines and cancer treatments. The company is leveraging AI technologies like the BFN generative protein model and DeepChain™ platform to enhance its immunotherapy pipeline.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 10:04 am